NEUROONE MEDICAL TECHNOLOGIES Corp
NeuroOne Medical Technologies Corporation (NASDAQ: NROF) is a medical technology company focused on developing minimally invasive diagnostic, ablation, and stimulation technologies for neurological and pain-related disorders. The company's core business centers on thin-film electrode technology designed for recording,… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What NEUROONE MEDICAL TECHNOLOGIES Corp does
In the company’s own words
NeuroOne Medical Technologies Corporation (NASDAQ: NROF) is a medical technology company focused on developing minimally invasive diagnostic, ablation, and stimulation technologies for neurological and pain-related disorders. The company's core business centers on thin-film electrode technology designed for recording, monitoring, and therapeutic applications across multiple clinical indications.
The company has received FDA 510(k) clearance for four devices: the Evo Cortical electrode for temporary brain surface recording and stimulation, the Evo sEEG electrode for subsurface brain recording and stimulation, the OneRF Brain Ablation System for functional neurosurgical procedures, and the OneRF TN Ablation System for trigeminal nerve ablation to treat chronic facial pain. In December 2025, NeuroOne initiated a limited market release of the OneRF TN Ablation System. Additional products in development include spinal cord stimulation systems, basivertebral nerve ablation technology, and drug delivery systems with integrated diagnostic capabilities.
NeuroOne's primary commercialization strategy involves an exclusive distribution agreement with Zimmer Biomet Holdings, Inc., which holds global rights to distribute the Evo Cortical, Evo sEEG, and OneRF Brain Ablation System. In fiscal 2025, the company generated approximately $9.1 million in product revenue from these distributed products. The company also pursues direct commercialization of the OneRF TN Ablation System and continues developing next-generation products targeting epilepsy, Parkinson's disease, essential tremors, dystonia, and chronic pain indications.
NeuroOne's technology platform leverages scalable, automated manufacturing processes for thin-film electrodes, providing cost advantages and manufacturing consistency. The company maintains intellectual property through licensed patents from the University of Wisconsin-Madison and Mayo Foundation, as well as owned patents covering neural depth electrodes, drug-delivering electrodes, and spinal cord stimulation systems. The company's research and development expenses totaled $5.0 million in fiscal 2025. NeuroOne operates as a smaller reporting company and is classified as a non-accelerated filer with the Securities and Exchange Commission. More information is available at www.neuroonemeded.com.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- EDEN PRAIRIE, MN
- Fiscal year end
- September
- CIK
- 1500198
- SIC
- 3841
Financial performance, year by year
Fiscal 2012–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns NEUROONE MEDICAL TECHNOLOGIES Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · NEUROONE MEDICAL TECHNOLOGIES Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do NEUROONE MEDICAL TECHNOLOGIES Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of NEUROONE MEDICAL TECHNOLOGIES Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in NEUROONE MEDICAL TECHNOLOGIES Corp's last four quarterly filings that the numbers alone won't show?”